Exploring Fairness and Performance Drivers Across State-of-the-Art Pulmonary Nodule Detection Algorithms

Lung cancer is the leading cause of cancer-related deaths in the UK. Its high mortality rate is primarily due to its asymptomatic nature in the early stages, leading to late-stage diagnoses. However, effective early detection methods, such as Low-Dose Computed Tomography (LDCT), and treatments for early-stage disease make lung cancer an ideal candidate for screening. The UK Government aims to implement a national lung cancer screening programme targeting high-risk populations by 2029. This will significantly increase the workload on an already stretched radiology workforce, driving the adoption of computer-aided detection (CADe) systems to support radiologists. The datasets used to train these algorithms are typically drawn from previous lung cancer screening trials and studies (National Lung Screening Trial Research Team (2011); de Koning (2020)), which often lack balanced representation of protected groups, such as sex and ethnicity. This project examines whether training nodule detection algorithms on low-dose computed tomography (LDCT) scans from a London-based lung screening study, where these groups are typically under-represented, affects algorithm performance for under-represented categories. Our results indicate that overall performance remains equitable across all categories, even when trained on unbalanced datasets. The discriminative performance of deep learning-based pulmonary nodule detection algorithms is primarily driven by the composition of the dataset, specifically, the relative proportion of nodule types and sizes, rather than by protected attributes such as sex or ethnic group. The features learned from the nodules themselves drive detection outcomes, meaning that in populations where the prevalent nodule characteristics closely match the training data, performance is likely to be strong. While this study found no demographic disparities for nodule detection, there is no guarantee that this will be true across all populations, particularly those in populations where cancer risk predominates within different nodule distributions. This study provides an early assessment of performance variations of deep learning models across under-represented groups within a standard lung cancer screening dataset. While previous research has focused on improving how well nodule detection algorithms identify pulmonary nodules, this study uniquely focuses on demographic performance disparities and the impact of training data composition and algorithm design on model generalisability. The findings highlight critical considerations for the deployment of CADe systems in lung cancer screening, ensuring equitable performance across diverse patient populations. Our code is available at <a href='https://github.com/johnmccabe44/fairness-in-nodule-detection'>https://github.com/johnmccabe44/fairness-in-nodule-detection</a>

Institutions

Publication Details

Journal
The Journal of Machine Learning for Biomedical Imaging
Published
2025-12-21
DOI
https://doi.org/10.59275/j.melba.2025-6838
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring Fairness and Performance Drivers Across State-of-the-Art Pulmonary Nodule Detection Algorithms

The Journal of Machine Learning for Biomedical Imaging
Lung Cancer Diagnosis and Treatment
article

Exploring Fairness and Performance Drivers Across State-of-the-Art Pulmonary Nodule Detection Algorithms

article en

Abstract

Lung cancer is the leading cause of cancer-related deaths in the UK. Its high mortality rate is primarily due to its asymptomatic nature in the early stages, leading to late-stage diagnoses. However, effective early detection methods, such as Low-Dose Computed Tomography (LDCT), and treatments for early-stage disease make lung cancer an ideal candidate for screening. The UK Government aims to implement a national lung cancer screening programme targeting high-risk populations by 2029. This will significantly increase the workload on an already stretched radiology workforce, driving the adoption of computer-aided detection (CADe) systems to support radiologists. The datasets used to train these algorithms are typically drawn from previous lung cancer screening trials and studies (National Lung Screening Trial Research Team (2011); de Koning (2020)), which often lack balanced representation of protected groups, such as sex and ethnicity. This project examines whether training nodule detection algorithms on low-dose computed tomography (LDCT) scans from a London-based lung screening study, where these groups are typically under-represented, affects algorithm performance for under-represented categories. Our results indicate that overall performance remains equitable across all categories, even when trained on unbalanced datasets. The discriminative performance of deep learning-based pulmonary nodule detection algorithms is primarily driven by the composition of the dataset, specifically, the relative proportion of nodule types and sizes, rather than by protected attributes such as sex or ethnic group. The features learned from the nodules themselves drive detection outcomes, meaning that in populations where the prevalent nodule characteristics closely match the training data, performance is likely to be strong. While this study found no demographic disparities for nodule detection, there is no guarantee that this will be true across all populations, particularly those in populations where cancer risk predominates within different nodule distributions. This study provides an early assessment of performance variations of deep learning models across under-represented groups within a standard lung cancer screening dataset. While previous research has focused on improving how well nodule detection algorithms identify pulmonary nodules, this study uniquely focuses on demographic performance disparities and the impact of training data composition and algorithm design on model generalisability. The findings highlight critical considerations for the deployment of CADe systems in lung cancer screening, ensuring equitable performance across diverse patient populations. Our code is available at <a href='https://github.com/johnmccabe44/fairness-in-nodule-detection'>https://github.com/johnmccabe44/fairness-in-nodule-detection</a>

The Journal of Machine Learning for Biomedical ImagingVol. 3(Special on FAIMI)
University College London Hospitals NHS Foundation Trust (GB), University of British Columbia (CA), Queen Mary University of London (GB), Hawkeye Community College (US), Living Streets (GB), MRC Unit for Lifelong Health and Ageing (GB), CRUK Lung Cancer Centre of Excellence (GB), University College London (GB)
American Association for Cancer Research, LUNGevity Foundation, AstraZeneca, GlaxoSmithKline, Gilead Sciences, Microsoft Research, F. Hoffmann-La Roche, Roy Castle Lung Cancer Foundation, Wellcome Trust, Cancer Research UK, National Institute for Health and Care Research, University College London, Rosetrees Trust, University College London Hospitals NHS Foundation Trust, UK Regenerative Medicine Platform, CRUK Lung Cancer Centre of Excellence, Stand Up To Cancer, Medical Research Council
Openalex Percentile: Top 40%
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.